New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
07:18 EDTCCXIChemoCentryx reports Q3 EPS (28c), consensus (22c)
Reports Q3 revenue $1.13M, consensus $4.75M
News For CCXI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
13:04 EDTCCXIOn The Fly: Midday Wrap
Subscribe for More Information
09:13 EDTCCXIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Adobe (ADBE), up 5.5% after reporting first quarter results and that it will acquire Fotolia for approximately $800 in cash. ALSO HIGHER: ChemoCentryx (CCXI), up 107.1% after Phase II clinical trial in diabetic nephropathy with CCX140 met its primary endpoint... Oncothyreon (ONTY), up 15.8% after announcing exclusive agreement with Array BioPharma (ARRY)... Talisman Energy (TLM), up 24.4% after a report that Repsol (REPYY) is preparing to make a C$6.00 per share bid... GoPro (GPRO), up 4.4% after being upgraded to Overweight from Neutral at JPMorgan. LOWER: Emerald Oil (EOX), down 18% after cutting fiscal 2015 guidance, naming new COO, and providing an updated fiscal 2015 development plan... Goodrich Petroleum (GDP), down 8.2% after being downgraded to Underweight from Overweight at JPMorgan... MEI Pharma (MEIP), down 3.9% after 10M share Secondary priced at $4.00... Heritage-Crystal Clean (HCCI), down 6.6% after 3.1M share Secondary priced at $10.00.
09:03 EDTCCXIChemoCentryx up 107.1% after Phase II trial met primary endpoint
Subscribe for More Information
06:46 EDTCCXIChemoCentryx to host conference call
Subscribe for More Information
06:38 EDTCCXIChemoCentryx reports Phase II nephropathy with CCX140 trial met primary endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use